DUBLIN, May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2024, which ended on Frida ...

Arecor Therapeutics plc ("Arecor" or the "Company") ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund Arecor's development of Arestat™ enabled novel, high concentration, thermostable insulin, specifically tailored for use in combination with a next-generation implantable pump Cambridge, UK, 9 May 2024: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier liv ...

The latest trading session saw Medtronic (MDT) ending at $81.76, denoting a +0.09% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 1.03% for the day. Elsewhere, the Dow gained 0.46%, while the tech-heavy Nasdaq added 1.19%. Prior to today's trading, shares of the medical device company had lost 3.39% over the past month. This has lagged the Medical sector's loss of 1.41% and the S&P 500's loss of 1.57% in that time. Market participants will be closely fo ...

Medtronic (MDT) ended the recent trading session at $80.86, demonstrating a +1.4% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.32%. Elsewhere, the Dow gained 0.38%, while the tech-heavy Nasdaq added 0.35%. The medical device company's shares have seen a decrease of 8.5% over the last month, not keeping up with the Medical sector's loss of 5.3% and the S&P 500's loss of 2%. Analysts and investors alike will be keeping a close eye on the performance of Medtron ...

Medtronic 公司新产品发布 - Medtronic 公司宣布美国食品和药物管理局（FDA）已批准 Inceptiv™ 闭环可充电脊髓刺激器（SCS）用于治疗慢性疼痛[1] - Inceptiv 是首款提供闭环功能的 Medtronic SCS 设备，能够实时感知脊髓上的生物信号，并自动调整刺激，使治疗与日常生活动作保持协调[1] - Inceptiv SCS 感知生物信号并始终保持医生规定的刺激，专门的电路和专有算法检测脊髓对电刺激的反应，以实时调整刺激[4]

Medtronic (MDT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this medical device company have returned -2.9%, compared to the Zacks S&P 500 composite's -3% change. During this period, the Zacks Medical - Products industry, which Medtronic falls in, has lost 2.7%. The key question now is: What could be the stock's future direction? ...

人工智能在医疗领域的应用 - 人工智能在医疗领域的应用有望提升人类健康状况[1] - 全球医疗人工智能市场价值预计将在2029年达到1484亿美元，年复合增长率为48.1%[3] 公司投入人工智能领域 - Stryker（NYSE:SYK）是一家专注于医疗设备领域的公司，去年宣布将大幅增加在人工智能领域的投入[5] - Medtronic（NYSE:MDT）是另一家专注于医疗设备的公司，致力于个性化医疗技术的发展[9] - Moderna（NASDAQ:MRNA）是一家生物技术公司，致力于疫苗和治疗方案的研发，近期宣布将AI融入公司的各个方面[12]

The most recent trading session ended with Medtronic (MDT) standing at $80.57, reflecting a +1.37% shift from the previouse trading day's closing. This change outpaced the S&P 500's 0.87% gain on the day. Elsewhere, the Dow gained 0.67%, while the tech-heavy Nasdaq added 1.11%. Coming into today, shares of the medical device company had lost 4.33% in the past month. In that same time, the Medical sector lost 6.67%, while the S&P 500 lost 3.97%. Analysts and investors alike will be keeping a close eye on the ...

Can this struggling healthcare specialist turn things around? Medtronic (MDT -0.21%) is a leading global medical device company with a massive presence that spans more than 150 countries. Its products assist patients with over 70 different health conditions. Investing in the stock is a potentially great way to gain exposure to the healthcare industry as a whole. Over the past five years, however, its shares have been a lackluster investment, falling by 8%. What should you do with Medtronic stock: buy, sell, ...

健康生活选择 - 美国成年人更倾向于选择健康短暂的生活而非长寿但伴随健康问题的生活[1] 预防性健康措施 - 美国成年人对于预防性健康措施的采取率较低，仅有39%的人进行定期体检，29%的人与医生讨论长寿问题[2] 医疗技术作用 - 医疗技术在帮助人们延长寿命和提高生活质量方面发挥着越来越重要的作用[3] - 医疗技术可以帮助人们更早地发现和治疗疾病，减轻慢性疾病的负担[4]